|
業務類別
|
-- |
|
業務概覽
|
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib),a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome. |
| 公司地址
| Darwinweg 24, Leiden, ZH, NLD, 2333 CR |
| 電話號碼
| +31 715247400 |
| 傳真號碼
| +31 715247445 |
| 公司網頁
| https://www.pharming.com |
| 員工數量
| 382 |
| Mr. Fabrice Chouraqui, M.B.A.,Pharm.D. |
Executive Director and Chief Executive Officer |
-- |
03/04/2025 |
| Dr. Alexander Breidenbach, PhD |
Chief Business Officer |
-- |
03/04/2025 |
| Mr. Ruud van Outersterp |
Chief Ethics and Compliance Officer |
-- |
03/04/2025 |
| Dr. Anurag Relan, M.D. |
Chief Medical Officer |
-- |
03/04/2025 |
| Ms. Mireille Sanders, M. Sc. |
Chief Operations Officer |
-- |
03/04/2025 |
| Mr. Stephen Toor |
Chief Commercial Officer |
-- |
03/04/2025 |
| Mr. Jeroen Wakkerman |
Chief Financial Officer |
-- |
03/04/2025 |
| Ms. Ines Bernal |
Chief People Officer |
-- |
03/04/2025 |
|
|
| Mr. Fabrice Chouraqui, M.B.A.,Pharm.D. |
Executive Director and Chief Executive Officer |
03/04/2025 |
| Dr. Richard Peters, M.D.,PhD |
Chairman of the Board |
03/04/2025 |
| Dr. Mark J. Pykett,PhD,V.M.D. |
Director |
03/04/2025 |
| Ms. Jabine van der Meijs |
Independent Director |
03/04/2025 |
| Mr. Leonard Kruimer |
Independent Director |
03/04/2025 |
| Ms. Deborah A. Jorn, M.B.A. |
Vice Chairman of the Board |
03/04/2025 |
| Mr. Steven Baert |
Director |
03/04/2025 |
| Ms. Barbara Yanni |
Director |
03/04/2025 |
|
|
|
|
